Marine polyphenol phlorotannins promote non-rapid eye movement sleep in mice via the benzodiazepine site of the GABAA receptor
- 578 Downloads
In psychopharmacology, researchers have been interested in the hypnotic effects of terrestrial plant polyphenols and their synthetic derivatives. Phlorotannins, a marine plant polyphenol, could have potential as a source of novel hypnotic drugs.
The effects of phlorotannins and major phlorotannin constituent eckstolonol on sleep–wake profiles in mice were evaluated in comparison with diazepam, and their hypnotic mechanism was also investigated.
The effects of phlorotannin preparation (PRT) and eckstolonol orally given on sleep–wake profiles were measured by recording electroencephalograms (EEG) and electromyograms in C57BL/6N mice. Flumazenil, a GABAA-benzodiazepine (BZD) receptor antagonist, was injected 15 min before PRT and eckstolonol to reveal its hypnotic mechanism.
PRT administration (>250 mg/kg) produced a significant decrease in sleep latency and an increase in the amount of non-rapid eye movement sleep (NREMS). Eckstolonol significantly decreased sleep latency (>12.5 mg/kg) and increased the amount of NREMS (50 mg/kg). PRT and eckstolonol had no effect on EEG power density of NREMS. The hypnotic effects of PRT or eckstolonol were completely abolished by pretreatment with flumazenil.
We demonstrated that phlorotannins promote NREMS by modulating the BZD site of the GABAA receptor. These results suggest that phlorotannins can be potentially used as an herbal medicine for insomnia and as a promising structure for developing novel sedative–hypnotics.
KeywordsGABAA-benzodiazepine receptor Hypnotic Marine polyphenols Phlorotannins Sleep promoting
This study was supported by grants from the Korea Food Research Institute (E0131402), Small and Medium Business Administration (G01981), the National Basic Research Program of China (2011CB711000, 2009ZX09303-006), the National Natural Science Foundation of China (31171010, 31121061, 31271164), the Shanghai Committee of Science and Technology (13140903100, 13dz2260700), and the Shanghai Leading Academic Discipline Project (B119).
Conflict of interest
All authors declare no conflicts of interest and had no disclosures.
- Cho S, Yang H, Jeon YJ, Lee CJ, Jin YH, Back NI, Kim DS, Kang SM, Yoon M, Yong H, Shimizu M, Han D (2012) Phlorotannins of the edible brown seaweed Ecklonia cava Kjellman induce sleep via positive allosteric modulation of gamma-aminobutyric acid type A-benzodiazepine receptor: a novel neurological activity of seaweed polyphenols. Food Chem 132:1133–1142CrossRefGoogle Scholar
- Kahnberg P, Lager E, Rosenberg C, Schougaard J, Camet L, Sterner O, Østergaard Nielsen E, Nielsen M, Liljefors T (2002) Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABAA receptor. J Med Chem 45:4188–4201PubMedCrossRefGoogle Scholar
- Sprenger KJ, Aneiro L, Fung L, Liu Y, Changchit A, Rajachandran L, Kehne JH, Xie L (2007) III Clinical trial data demonstrating sedative-hypnotic efficacy of the α3-subunit preferring GABAA receptor partial allosteric activator, NG2–73: translational validity of pharmacokinetic/pharmacodynamic (PK/PD) relationships derived from preclinical studies. Program no. AAA17. Neuroscience Meeting Planner. Society for Neuroscience Online, San Diego.Google Scholar
- Trevor AJ, Way WL, Katzung BG (2007) Sedative-hypnotic drugs. McGraw-Hill Medical, New YorkGoogle Scholar
- Wolfman C, Viola H, Marder M, Ardenghi P, Wasowski C, Schroder N, Izquierdo I, Ruveda E, Paladini A, Medina JH (1998) Pharmacological characterization of 6-bromo-3′-nitroflavone, a synthetic flavonoid with high affinity for the benzodiazepine receptors. Pharmacol Biochem Behav 61:239–246PubMedCrossRefGoogle Scholar